Synthesis and Antitumor Evaluation of Bis Aza-anthracene-9,10-diones and Bis Aza-anthrapyrazole-6-ones

This publication has 33 references indexed in Scilit:

• BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)
  Investigational New Drugs, 2005
• Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
  Cancer Gene Therapy, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Tumor necrosis factor receptor-associated factors (TRAFs)
  Oncogene, 2001
• Synthesis and Antitumor Evaluation of 2,5-Disubstituted- Indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-Aza-anthrapyrazoles)
  Journal of Medicinal Chemistry, 1998
• Mitoxantrone
  Drugs & Aging, 1997
• Synthesis of regioisomeric 6,9-(chlorofluoro)-substituted benzo[g]quinoline-5,10-diones, benzo[g] isoquinoline-5,10-diones and 6-chloro-9-fluorobenzo[g]quinoxaline-5,10-dione
  Journal of Heterocyclic Chemistry, 1997
• Mitoxantrone
  Drugs & Aging, 1996
• 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations
  Journal of Medicinal Chemistry, 1994
• Mitoxantrone
  Drugs, 1991